Cargando…
Tackling Inflammatory Bowel Diseases: Targeting Proinflammatory Cytokines and Lymphocyte Homing
Inflammatory bowel diseases (IBDs) are characterized by chronic inflammatory disorders that are a result of an abnormal immune response mediated by a cytokine storm and immune cell infiltration. Proinflammatory cytokine therapeutic agents, represented by TNF inhibitors, have developed rapidly over r...
Autores principales: | Song, Yijie, Yuan, Man, Xu, Yu, Xu, Hongxi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502105/ https://www.ncbi.nlm.nih.gov/pubmed/36145301 http://dx.doi.org/10.3390/ph15091080 |
Ejemplares similares
-
Manipulating Microbiota in Inflammatory Bowel Disease Treatment: Clinical and Natural Product Interventions Explored
por: Zhu, Mengjie, et al.
Publicado: (2023) -
Proinflammatory cytokines in irritable bowel syndrome: a comparison with inflammatory bowel disease
por: Mitselou, Antigony, et al.
Publicado: (2020) -
The association of the quality of sleep with proinflammatory cytokine profile in inflammatory bowel disease patients
por: Sobolewska-Włodarczyk, Aleksandra, et al.
Publicado: (2021) -
Cytotoxic synergism of Clostridioides difficile toxin B with proinflammatory cytokines in subjects with inflammatory bowel diseases
por: Bassotti, Gabrio, et al.
Publicado: (2023) -
B Lymphocyte intestinal homing in inflammatory bowel disease
por: Defendenti, Caterina, et al.
Publicado: (2011)